Laura Spring, M.D.
NPI 1811282957 · Medical Oncology Physician · Boston, MA
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Laura Spring, M.D. is a Medical Oncology Physician provider in Boston, MA (NPI 1811282957).
Provider details
- NPI number
- 1811282957
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 256404 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
995 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 229 | $151 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 227 | $17 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 152 | $102 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 140 | $124 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 78 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Letrozole | 110 | 44 |
| Exemestane | 25 | 11 |
| Anastrozole | 21 | — |
| Palbociclibbrand: Ibrance | 21 | — |
| Tamoxifen Citrate | 14 | — |
| Apixabanbrand: Eliquis | 12 | — |
| Alendronate Sodium | 11 | — |
Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means , never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$20,291 across 20 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 75 Francis StBoston, MA 02115-6106Phone: (617) 732-5500
Registry dates
- Enumerated
- 2011-06-16
- Last updated
- 2026-01-13
- Certified
- 2026-01-13
Frequently asked questions
- What is Laura Spring's NPI number?
- Laura Spring's National Provider Identifier (NPI) is 1811282957, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Laura Spring's specialty?
- Laura Spring is listed in the NPPES registry with a primary specialty of Medical Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Laura Spring located?
- Laura Spring's practice location on file with NPPES is 55 Fruit St, Boston, MA 02114-2621.
- What is Laura Spring's phone number?
- The practice phone number listed in the NPPES registry for Laura Spring is (617) 724-4000.
- Does Laura Spring accept Medicare?
- Laura Spring is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Laura Spring's NPI active?
- Yes — Laura Spring's NPI (1811282957) is active in the NPPES registry as of the last update on 2026-01-13.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.